江中药业：2025年通过加强品牌打造和优化费用结构等措施，实现净利润9.06亿元

Core Viewpoint - Jiangzhong Pharmaceutical reported a revenue of 4.22 billion yuan, a year-on-year decrease of 4.87%, while the net profit attributable to shareholders increased by 14.96% to 906 million yuan [1] Group 1: Financial Performance - The company achieved an operating income of 4.22 billion yuan, reflecting a decline of 4.87% compared to the previous year [1] - The net profit attributable to shareholders reached 906 million yuan, showing a growth of 14.96% year-on-year [1] Group 2: Strategic Measures - The company faced structural adjustment pressures within the industry during the reporting period [1] - To enhance profitability, the company implemented measures such as strengthening brand development and optimizing cost structure [1]